The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Medtronic PLC

NYSE: MDT
Last

(U.S.) $76.03

Today's change+0.37 +0.49%
Updated July 28 10:11 AM EDT. Delayed by at least 15 minutes.
 

Medtronic PLC

NYSE: MDT
Last

(U.S.) $76.03

Today's change+0.37 +0.49%
Updated July 28 10:11 AM EDT. Delayed by at least 15 minutes.

Medtronic PLC crosses above 50-day moving average

Medtronic PLC is up today by (U.S.)$0.37 or 0.49% to (U.S.)$76.03 and crossing above its 50-day moving average. Shares have lost 0.67% over the last five days, but sit 4.36% below their 52-week high. This security has outperformed the S&P 500 by 16.43% during the last year.

Key company metrics

  • Open(U.S.) $76.29
  • Previous close(U.S.) $75.66
  • High(U.S.) $76.44
  • Low(U.S.) $75.78
  • Bid / Ask(U.S.) $76.02 / (U.S.) $76.03
  • YTD % change+5.30%
  • Volume432,148
  • Average volume (10-day)4,220,427
  • Average volume (1-month)5,258,774
  • Average volume (3-month)5,229,390
  • 52-week range(U.S.) $59.83 to (U.S.) $79.50
  • Beta1.10
  • Trailing P/E28.36×
  • P/E 1 year forward17.30×
  • Forward PEG2.62×
  • Indicated annual dividend(U.S.) $1.52
  • Dividend yield2.00%
  • Trailing EPS(U.S.) $2.68
Updated July 28 10:11 AM EDT. Delayed by at least 15 minutes.
S&P TSX0.31%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedApr 24, 201504/24/2015Jan 23, 201501/23/2015Oct 24, 201410/24/2014Jul 25, 201407/25/2014
Revenue7,3044,3184,3664,273
Total other revenue--------
Total revenue7,3044,3184,3664,273
Gross profit4,3703,1903,2243,168
Total cost of revenue2,9341,1281,1421,105
Total operating expense6,9232,8903,2553,185
Selling / general / administrative2,4041,4871,5071,506
Research & development528373374365
Depreciation / amortization468898987
Interest expense (income), net operating--------
Unusual expense (income)617-5816171
Other operating expenses, total-28-129-1851
Operating income3811,4281,1111,088
Interest income (expense), net non-operating-299-176-94-97
Gain (loss) on sale of assets--------
Other--------
Income before tax1871,1941,0221,083
Income after tax-1977828871
Income tax, total188217194212
Net income-1977828871
Total adjustments to net income--------
Net income before extra. items-1977828871
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1977828871
Inc. avail. to common incl. extra. items-1977828871
Diluted net income-1977828871
Dilution adjustment--0----
Diluted weighted average shares1,4249969931,005
Diluted EPS excluding extraordinary itemsvalue per share0.000.980.830.87
Dividends per sharevalue per share0.310.310.310.31
Diluted normalized EPSvalue per share0.280.960.940.91